Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

761 trials with published results (21%)

Research Maturity

2595 completed trials (71% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.2%

189 terminated out of 3630 trials

Success Rate

93.2%

+6.7% vs benchmark

Late-Stage Pipeline

27%

991 trials in Phase 3/4

Results Transparency

29%

761 of 2595 completed with results

Key Signals

761 with results93% success189 terminated

Data Visualizations

Phase Distribution

2,944Total
Not Applicable (1217)
Early P 1 (18)
P 1 (413)
P 2 (305)
P 3 (547)
P 4 (444)

Trial Status

Completed2,595
Unknown367
Recruiting213
Terminated189
Active Not Recruiting86
Withdrawn72

Trial Success Rate

93.2%

Benchmark: 86.6%

Based on 2595 completed trials

Clinical Trials (3630)

Showing 20 of 20 trials
NCT07064473Phase 3RecruitingPrimary

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT05370781Not ApplicableCompletedPrimary

Michigan Men's Diabetes Project 2

NCT06493955Not ApplicableNot Yet RecruitingPrimary

Evaluation of the Effectiveness of Extending the "Passerelle" System for Prescribing Adapted Physical Activity to Patients With Type 2 Diabetes in Nouvelle-AQUItaine (France)

NCT04284943Not ApplicableRecruiting

Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery

NCT06571474Recruiting

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

NCT06092476Not ApplicableActive Not RecruitingPrimary

Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes Patients

NCT05984238Not ApplicableCompletedPrimary

A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapy

NCT06066528Phase 3Completed

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

NCT06267391Not ApplicableActive Not Recruiting

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes

NCT06080425Not ApplicableCompletedPrimary

Promoting Intergenerational Health in Rural Kentuckians With Diabetes (PIHRK'D)

NCT06296485Not ApplicableRecruitingPrimary

Safer Aging With Diabetes Monitoring

NCT01878045Completed

Mechanisms of Diabetic Kidney Disease in American Indians

NCT07745998Not ApplicableNot Yet Recruiting

The BRIGHT Study (Device Name: HALO System)

NCT07197788Not ApplicableEnrolling By Invitation

Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

NCT03811561Phase 3Active Not RecruitingPrimary

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

NCT01105858SuspendedPrimary

Molecular and Clinical Profile of Diabetes Mellitus and Its Complications

NCT00445627Completed

Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus

NCT06046833Not ApplicableRecruitingPrimary

Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes

NCT07590193Phase 1RecruitingPrimary

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

NCT07428746Phase 3RecruitingPrimary

Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes

Scroll to load more

Research Network

Activity Timeline